Centre de Recherche de l'Hopital Ste-Justine – Trademark Portfolio

Entity Type: 99

Centre de Recherche de l'Hopital Ste-Justine holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. The owner is based in Montreal, Quebec.

3175 chemin de la Cote Ste-Catherine

Montreal, Quebec H3T1C5 , CA

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Centre de Recherche de l'Hopital Ste-Justine's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Centre de Recherche de l'Hopital Ste-Justine have?

Centre de Recherche de l'Hopital Ste-Justine has 1 U.S. trademark filed with the USPTO.

What trademark classes does Centre de Recherche de l'Hopital Ste-Justine file in?

Centre de Recherche de l'Hopital Ste-Justine files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Centre de Recherche de l'Hopital Ste-Justine's trademark registration success rate?

Centre de Recherche de l'Hopital Ste-Justine has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.